VolitionRx Ltd
VNRX
28 hedge funds and large institutions have $4.66M invested in VolitionRx Ltd in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.
2,700% more call options, than puts
Call options by funds: $28K | Put options by funds: $1K
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
7% more capital invested
Capital invested by funds: $4.35M → $4.66M (+$316K)
0.01% more ownership
Funds ownership: 0.4% → 0.41% (+0.01%)
0% more funds holding
Funds holding: 28 → 28 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.1K |
| 2 |
Morgan Stanley
New York
|
+$44.9K |
| 3 |
VF
Virtu Financial
New York
|
+$19.6K |
| 4 |
BlackRock
New York
|
+$17.9K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
-$113K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$12.1K |
| 3 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$7.32K |
| 4 |
SM
Sensible Money
Scottsdale,
Arizona
|
-$6.89K |
| 5 |
Jane Street
New York
|
-$5.48K |
VNRX Hedge Fund Activity: Q4 2023 in Review
28 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q4 2023, worth a combined $4.66M — up 7.3% from $4.35M a quarter earlier.
Fund positioning in VNRX was balanced in Q4 2023: 6 funds opened new positions, 6 closed out, 8 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $64.1K. The largest seller was Lagoda Investment Management, cutting an estimated $113K.
- 28 institutional investors held VolitionRx Ltd (VNRX) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $4.66M of VolitionRx Ltd stock for Q4 2023, up 7.3% quarter-over-quarter.
- 6 funds opened new VolitionRx Ltd positions in Q4 2023 and 6 closed out, a net change of 0 holders.
- The largest VolitionRx Ltd buyer in Q4 2023 was Vanguard Group, an estimated $64.1K added.
- The largest VolitionRx Ltd seller in Q4 2023 was Lagoda Investment Management, an estimated $113K sold.
Based on aggregated 13F filings for Q4 2023.